Dr. Farhaad Rahman Riyaz, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 6505 Rockside Rd Ste 475, Independence, OH 44131 Phone: 216-573-5900 |
Connie D Sutter, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6701 Rockside Rd, Suite 330, Independence, OH 44131 Phone: 216-524-4009 Fax: 216-524-7933 |
Dr. Pamela Ng, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5001 Rockside Rd, Dermatology In40, Independence, OH 44131 Phone: 216-986-4140 Fax: 216-986-4923 |
Marlene Willen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6701 Rockside Rd Ste 330, Independence, OH 44131 Phone: 216-524-4009 Fax: 216-524-7933 |
Mary Teresa Sivik, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6701 Rockside Rd, Suite 330, Independence, OH 44131 Phone: 216-524-4009 Fax: 216-524-7933 |
Carol G Burg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6701 Rockside Rd, Suite 330, Independence, OH 44131 Phone: 216-524-4009 Fax: 216-524-7933 |
News Archive
With tens of thousands of people set to travel abroad over the Christmas period, AA Travel Insurance are today urging travellers to be properly vaccinated before travelling.
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop a pharmacodynamic assay to monitor the Akt/mTOR signaling pathway.
California Assemblyman Bill Monning, chair of the Assembly Committee on Health introduced AB 1453, which laid out a plan for what essential benefits will be covered in California under the Affordable Care Act. The proposed set of benefits is modeled on the Kaiser small group HMO plan
People living with the human immunodeficiency virus (HIV) who have a history of severe immunosuppression and at least one copy of the Alzheimer's disease-related gene variant APOE4, might see a compounded adverse effect on the circuitry that impacts memory.
Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, announced that it has completed the first close on its Series B equity financing of up to $25 million led by SV Life Sciences (SVLS) along with existing investor, Kleiner Perkins Caufield & Byers (KPCB).
› Verified 5 days ago